Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Follicum AB receives Notice of Allowance from the US Patent Office for the protection of the company's peptides developed for the treatment of diabetes and its related complications

Follicum AB ("Follicum") has received information that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance of the US patent application 16/666,960. The patent application covers the company's peptides and their use for treatment of diabetes and diabetes-associated complications.The application is directed to new peptides from the company's two peptide classes, and their use in the treatment of diabetes and its complications. Follicum has now received Notice of Allowance for this application. In short, a Notice of Allowance means that the patent office in

Inhalation Sciences signs new CRO contract worth 75 KEUR with returning global pharma client

(Stockholm, 22 June 2020) Inhalation Sciences (ISAB) has signed a new CRO (Contract Research) order worth 75 KEUR for a project using its in vitro lung simulation tool DissolvIt[®]. The contract is with a returning CRO client—a noted global pharma company. CEO Manoush Masarrat: “This new order from a returning client underlines the benefits DissolvIt[®] gives inhaled drug developers. The voluminous, precise data DissolvIt[® ]deliver are, quite simply, leading. It’s a world-class solution. This new order confirms it once again.”Contract Research has long been an essential part of ISAB’s

FINAL ASSAYS CONFIRM HIGH NICKEL SULPHIDE DISCOVERY AT CORCEL PROJECT

Eurobattery Minerals AB (Nordic Growth Market: "BAT"; “the Company”) a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, today announces the final results for sulphide mineral tests at the nickel, cobalt, copper Castriz prospect in Galicia, northwest Spain. In the larger Corcel project, Castriz is one of three primary prospects together with Monte Mayor and Monte Castello. Key points: · Final assay results received from nickel sulphide (Ni•S) assays on mineralised samples from recent drilling at

Pomegranate Investment AB (publ) releases Financial Report for the period of 6 months ended April 30, 2020 and 12 months ended April 30, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONHighlight of the reporting period · The net asset value of the Company was EUR 118.2 mln as per April 30, 2020 corresponding to EUR 21.9 per share, compared with NAV per share of EUR 21.1 as per October 31, 2019. · Digikala achieved 137% growth in NMV in Iranian year 1398 and reached positive adjusted EBITDA for the year as well as achieved many performance records, including highest number of Monthly Active Users – 26 M and highest Daily Net Order – 160 thousand. · Iranian stock market reached new all-time highs,

CEO Renée Aguiar-Lucander exercises warrants and invests SEK 15.7m (appr. USD 1.7m) in Calliditas

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that its CEO Renée Aguiar-Lucander will exercise warrants granted pursuant to Calliditas’ Warrant Program 2017/2020, which corresponds to an investment totaling SEK 15.7 million. Following the exercise, Ms. Aguiar-Lucander’s total shareholding in Calliditas corresponds to 412,000 shares.For further information, please contact: Renée Aguiar-Lucander, CEO, Calliditas Email: renee.lucander@calliditas.com Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications Email: mikael.widell@calliditas.com

Vicore Pharma's drug candidate VP01 demonstrates potential for significant benefit in severe pulmonary hypertension

Gothenburg, June 22, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, announces positive results with VP01 in a gold-standard preclinical model considered predictive of human pulmonary hypertension.Administration of clinically relevant oral doses of VP01 in the so called Sugen-Hypoxia-induced pulmonary hypertension (PH) model in rats caused a significant and therapeutically meaningful reduction in pulmonary arterial pressure without affecting the systemic blood pressure. In addition, VP01 significantly

AnnaCarin Grandin new CEO at Coor

AnnaCarin Grandin has been appointed CEO of Coor, effective from 1 August 2020. AnnaCarin Grandin replaces Mikael Stöhr who has chosen to leave the company.AnnaCarin Grandin previously held the position of CEO of Coor Sweden. She has been with Coor for 19 years, and has worked in several roles in the company, including CEO of Coor in Norway, Business Unit President and Contract Manager. AnnaCarin Grandin also has experience from the Swedish Association of Local Authorities and Regions and Dalkia (now Lassila & Tikanoja). “I’m delighted that AnnaCarin has accepted the position as CEO. She

Bank collaboration in Helgeland – the Norwegian Competition Authority has cleared the transaction

Reference is made to stock exchange notice of 18 March stating that SpareBank 1 Nord-Norge and Helgeland Sparebank are to establish a strategic, future-oriented collaboration. SpareBank 1 Nord-Norge will become a long-term owner of Helgeland Sparebank with a 19.99% stake of the bank’s equity certificates. For its part, Helgeland Sparebank will acquire SpareBank 1 Nord-Norge’s banking business linked to the branches in Helgeland. Helgeland Sparebank will concurrently join the SpareBank 1 Alliance by becoming part of SamSpar. On 19 June 2020, the Norwegian Competition Authority cleared the

Are these the chocolatey classics of tomorrow? Fazer to begin presales of plant-based oat choco and milk chocolate with no added sugar

Fazer is responding to customer wishes and rising food trends by introducing two new chocolatey innovations. Fazer is introducing two new small tablets, plant-based Fazer Oat Choco and Karl Fazer Crispy Mint milk chocolate with no added sugar. They will be available as limited editions at Fazer’s own sales outlets from 24 June.Customers have been asking Fazer for new additions to our range of chocolates, and now these wishes are being fulfilled. “Our talented chocolate technologists managed to develop delicious solutions to two challenges: a plant-based product and a chocolate with no added

Väderstad presents the new Marathon 15/25 point – for heavy clay duty

Väderstad introduces the new Marathon 15/25 tine harrow point, which provides guaranteed working depth in the heavier soils. Together with the wider Marathon 25/35, the tine harrow Marathon family is now complete.The 15/25 is a further specialization addition to the Marathon 25/35 introduced in 2018. – Don’t be fooled by the smaller size, this is an extremely tough point. It has a narrow bottom of just 15 millimeters with a pointy shape, which means that it can maintain the working depth even in tough soil conditions with heavy clay. It has an even higher soil penetration ability than

Azelio signs MoU with partner in Mexico for energy storage supply to commercial and industrial customers

Azelio has signed a Memorandum of Understanding (MoU) with Mexican, CITRUS JMK S.A DE C.V (CITRUS) to assess energy storage for the food and beverage, agricultural, mining, and the oil & gas industry as well as the tourism sector with hotels and resorts in Mexico, North and Central America. The MoU frameworks a collaboration over a 20 MW capacity of Azelio’s energy storage until 2024. The parties expect to trigger further projects in addition to this initial agreement.Azelio’s long-duration energy storage system coupled to Solar PV will be part of CITRUS offer to their clients within the C&

Safety in intraoral and extraoral imaging during the pandemic

Intraoral and extraoral imaging both have specific benefits and disadvantages that should be considered in times of the COVID-19 pandemic. The safest and most suitable imaging option often depends on the individual situation of a clinic.Reducing droplets with extraoral imaging The coronavirus pandemic has changed the way dental clinics operate in many parts of the world. For the time being, all procedures need to be carefully rethought and reorganised to ensure maximal patient and staff safety, especially in areas where the virus is still known to spread. While international dental

Väderstad presents the new Marathon 15/25 point – for heavy clay duty

Väderstad introduces the new Marathon 15/25 tine harrow point, which provides guaranteed working depth in the heavier soils. Together with the wider Marathon 25/35, the tine harrow Marathon family is now complete.The 15/25 is a further specialization addition to the Marathon 25/35 introduced in 2018. – Don’t be fooled by the smaller size, this is an extremely tough point. It has a narrow bottom of just 15 millimeters with a pointy shape, which means that it can maintain the working depth even in tough soil conditions with heavy clay. It has an even higher soil penetration ability than

Powerbox and AMETEK Programmable Power sign distribution agreement for Nordic countries and Portugal

Powerbox, one of Europe’s largest power supply companies and for more than four decades a leading force in optimizing power solutions for demanding applications, has announced it has signed a new, multi-year distribution agreement with AMETEK Programmable Power for the Nordic countries of Denmark, Finland, Norway, Sweden, and also Portugal in southern Europe.In supporting customers’ product and system requirements for demanding applications, Powerbox (PRBX) has enjoyed a mutually fruitful business relationship for more than 15 years with AMETEK Programmable Power. The new

Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020

Oslo, Norway, 22 June, 2020 – Targovax ASA, a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that Magnus Jäderberg, Chief Medical Officer of Targovax, will present an overview of the company at the upcoming Virtual European Biotech Investor Day 2020  hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq.  Participants will be able to submit questions electronically during the presentation, with answers provided at

Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit

· Encouraging PFS and survival data in ONCOS-102-treated first line patients as 31 patients have now completed 12 months follow-up · Mechanistic evidence of profound immune activation in ONCOS-102-treated patients associated with better clinical outcomes · Immune activation data provides clear scientific rationale for anti-PD1/L1 checkpoint inhibitor combination in upcoming trial in first line mesothelioma Oslo, Norway, 22 June 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today releases

FILO MINING APPOINTS JAMIE BECK AS PRESIDENT & CEO AND ANNOUNCES NEW BOARD COMPOSITION

Vancouver, BC, June 22, 2020 /CNW/ - Filo Mining Corp. (TSXV, Nasdaq First North Growth Market: FIL) ("Filo Mining”, “Filo”, or the “Company”) announces the appointment of Mr. Jamie Beck as President & Chief Executive Officer (“CEO”) and Director of the Company. Also elected to the Board is Ms. Erin Johnson, Managing Director of the Lundin Foundation. At the same time, Mr. Adam I. Lundin has stepped down as Filo Mining’s CEO and transitioned to Chairman of the Board. As Chairman, Mr. Lundin takes over from his father, Mr. Lukas H. Lundin, who will continue to serve as a Director of the

World Refugee Day: Ingka Group reiterates its commitment to refugees

· Company rolls out job training, language skills initiatives for refugees in 30 countriesIKEA Retail (Ingka Group) will continue to roll out a skills for employment concept for refugees in 30 countries this year as a part of its commitment to support refugees. Ingka Group will do this through job training and language skills initiatives in 300 IKEA units, the company says, reiterating its commitment to refugees in honour of World Refugee Day  on June 20. At the first Global Refugee Forum in Switzerland in December 2019, Ingka Group had announced that 2,

Read original

SDRL – Seadrill Limited Transitions to Quotation on OTC Capital Markets OTCQX

Hamilton, Bermuda, June 19, 2020 – Seadrill Limited ("Seadrill" or the "Company") today announces that further to its press release dated June 1, 2020, and as part of the delisting of  its common shares (the "Common Shares") from the New York Stock Exchange (NYSE), the completion of its transition to the United States’ OTCQX Market.  The Company filed a Form 25 with the U.S. Securities and Exchange Commission (the “SEC”) on June 11, 2020 in order to delist its common shares from the NYSE, which occurs ten days thereafter upon effectiveness of the Form 25. Accordingly, the Company’s last

Following European Parliament resolution, Czech government must finally act on PM’s conflict of interest

Issued by TI Czech RepublicA resolution passed today in the European Parliament regarding Czech Prime Minister Andrej Babiš’s ongoing conflict of interest. It is a welcome further recognition of misuse of public funds by the Prime Minister. The resolution, which passed 520 votes to 53 with 101 abstentions, comes exactly two years to the day since Transparency International Czech Republic (TI CZ) brought to light evidence  that PM Babiš retains control of companies that receive millions in the Czech and

Share buyback programme completed

Reference is made to the stock market announcement on 27 February 2020, where Norwegian Energy Company ASA ("Noreco" or the "Company") announced an initiation of a share buyback programme of up to 160,000 of its own shares. After the completion of the buyback programme, Noreco owns 438,161 of its own shares. The buyback programme was executed in accordance with the authorization given by Noreco's general meeting. The information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  ***

ShaMaran Atrush May Oil Sales Payment Received

Vancouver, BC, June 19, 2020 /CNW/ -  ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (SNM - TSXV, Nasdaq First North Growth Market) provides the following update to stakeholders.  The Company confirms that a payment of $6.9 million ($2.5 million net to the Company) has been received from the Kurdistan Regional Government (“KRG”) for Atrush crude oil sales during May 2020.   OTHER This information is information that ShaMaran Petroleum Corp is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency

There are no items matching the current filter
There are no more items matching the current filter
Back to top